Filing
Registration
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jun 10, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New Jersey
Lobbying activity
1
FDA modernization policy issues General issues related to rare disease and clinical trials General issues related to diagnostics for patients with rare diseases Issues related to drug pricing Issues related to reform of pharmacy benefit managers Issues related to trade Issues related to Newborn Screening and Genetic Testing
Foreign interests disclosed
1
-
KYOWA KIRIN CO., LTDJapan · Chiyoda-ku, Tokyo 100-0004 · owns 100% of the client · contributed $0.00